Hybrid ODM: Customising a Base Formula Without Full Development

Most brands do not arrive at a manufacturer with a formula. They arrive with a product idea, a claim, a pack they have already half designed, and a budget that does not stretch to a full development programme. The choice they are usually offered is between an off-the-shelf base with their name on it and a custom formula built from nothing, and the second option is more expensive and slower than most first-time brands expect. Between those two sits a third route that the industry uses constantly and describes badly: starting from a base that has already been validated and changing a defined set of things within it.

The reason this works is that a validated base is not just a formula. It is a formula with a safety assessment, a stability study and a manufacturing history behind it, and a defined envelope within which those documents remain valid. Customising inside the envelope is fast and cheap because the studies carry over. Customising outside it is not, because the studies have to be repeated. Knowing where the line sits is the whole of the decision.

What the middle path actually is

A base formula is a developed and documented product that a manufacturer produces routinely, with an established raw material supply position and a manufacturing process that the plant runs without special set-up. It has a proven shelf life in a defined pack, a preservative system that has passed challenge testing, and a safety assessment that covers the formula as written. All of that exists before the brand is involved.

What the brand brings is the differentiation: a fragrance, a colour, a texture adjustment, a packaging direction, a claim it wants to make, and a price point. A hybrid project is the exercise of fitting those onto the base without moving any of the components the documentation depends on. When it is done well, the brand gets a product that is genuinely its own in the ways a customer can perceive, at a cost and a lead time closer to private label than to full development.

The limitation is that the result is a variation on something that exists rather than something new. A brand whose entire proposition is a novel format, an unusual texture or a claim no existing base can support is not in the hybrid category, and pretending otherwise leads to a project that is priced like a hybrid and delivered like a custom development, usually late.

What a validated base buys you

The first thing it buys is time. A base formula skips discovery, the first sampling loop and the failure modes that a new emulsion or a new surfactant system always produces. The second thing is risk. A base that has been produced for several years has accumulated real manufacturing experience, including the batch variations that only show up at scale, and the process tolerances have already been tightened around them.

The third thing it buys is documentation. The safety assessment exists, the challenge test result exists, the stability data exists in at least one pack format, and the raw material specifications are on file. Those documents are the expensive part of development and the part that brands most often underestimate, because they are invisible in a sample.

The fourth is the supply position. A base formula consumes raw materials the manufacturer already buys in volume, which means the brand is not exposed to a minimum order quantity on a specialty ingredient and is not carrying the lead time of a material nobody stocks. For a first launch or a small volume, that difference is often what makes the project viable at all.

The variables you can change without restarting the file

Fragrance is the clearest case. A base formulated without fragrance or with a fragrance that can be replaced allows the brand to select from a library or commission a development, and the change is covered by odour evaluation and a stability check rather than a full study. The constraint is the dose: staying within the range the base was designed around keeps the emulsion, the preservative system and the viscosity where they were.

Colour follows similar logic where the base is either colourless or lightly coloured and the colourant is declared. A tint within the range the system tolerates is covered by a stability check on the finished shade and, where light exposure matters, a light-stability check. Moving from a clear product to an opaque one is a different matter, because opacity changes how the product behaves under light and how the pack looks half empty.

Viscosity and texture are changeable within a band. Most systems respond to a thickener or a salt curve, and adjusting within the proven band is a routine exercise that the manufacturer can run in a day. Texture moves further when an emollient is swapped for another of similar polarity and similar spreading behaviour, because the emulsifier system sees a comparable oil phase. Swapping an emollient for one of a different polarity, or adding a large amount of a new oil, changes the emulsifier requirement and therefore the study position.

Active level is the variable that most brands want to move and the one that has the least room. Where the base was designed with a range in mind, adjusting inside that range is straightforward. Where the brand wants a level the base was never built for, the safety assessment and, in some cases, the claim both have to be revisited, and the project stops being a hybrid at that point.

The five changes that restart the clock

The preservative system is the most consequential. A change to the preservative, or a change that alters the water activity or the pH enough to affect preservative performance, invalidates the challenge test and requires a new one. A challenge test has a fixed read schedule and cannot be accelerated by running more samples, so this single change adds three months to a project regardless of how small it looks.

The pH is the second. Moving the pH changes preservative performance, thickener behaviour, the stability of pH-sensitive actives and sometimes the colour. A small move within the base's proven range is covered by the existing data; a move beyond it is a new system.

The emulsifier system is the third. Any change to the emulsifier pair, its ratio or its level reopens the stability question, because emulsion stability is a function of that system rather than of the formula as a whole. The fourth is the surfactant system in a cleansing product, where a change to the primary surfactant alters viscosity, foam character, mildness and the salt curve all at once.

The fifth is the ultraviolet filter set, which in most markets brings its own testing regime including protection performance measurement. A sunscreen base is not a base that can be modified casually, and the documentation burden makes it closer to a full development than to a variation.

How the studies are carried over

The mechanism that makes a hybrid cheap is that a small change inside a validated envelope can be covered by the existing studies, supported by a shorter confirmation on the modified product. The confirmation usually runs one month at elevated temperature plus a freeze-thaw cycle, with a viscosity, pH, appearance and odour check at each point, and a preserved product also gets a microbiological check at the end.

Where more than one variable moves, the assessment turns into a bracketing exercise: the manufacturer identifies the worst case among the variants and runs the confirmation on that one, on the reasoning that the intermediate versions are less demanding. Bracketing is legitimate and widely used, and it depends on a defensible argument about which variant is worst rather than on convenience. The argument has to be documented, because it is the basis for the claim that the untested variants are covered.

The safety assessment is a separate question from the stability one. A change of fragrance, colour or emollient alters the ingredient list, and the assessment has to cover the product as it will actually be sold. Many manufacturers hold an assessment that covers a defined set of permitted variations, which is precisely what makes a hybrid project quick. When the variation falls outside that set, the assessment is amended or redone, and the time that takes depends on the assessor rather than on the lab.

MOQ and the raw material position

Minimum order quantity in a hybrid project is driven by different things than in a full development. Because the raw materials are already stocked, the binding constraint is usually the batch size of the plant rather than a supplier minimum, and the second constraint is the packaging. Where the packaging is a stock component the brand already uses, the minimum is often set by the manufacturer's smallest economic batch. Where the packaging is new, the tooling and the component minimums take over and can exceed the fill minimum substantially.

The batch size the manufacturer can run also interacts with the range. A brand launching four SKUs will often find that the total volume matters more than the per-SKU volume, because the plant can group the variants into one production sequence sharing the base. That is one of the practical advantages of a hybrid model over four independent custom formulas, and it is worth asking about explicitly rather than assuming.

Development fees work differently too. A hybrid project has a lower fee, and manufacturers often credit part or all of it against the first production order at a defined volume. The credit is worth confirming in writing at the quotation stage rather than at the point of the order, because the terms vary and the difference is material for a first launch.

Cost and timeline compared

Against a full development, a hybrid project typically saves several weeks of sampling and most of an initial stability study, and the saving is largest when the brand changes only fragrance, colour and packaging. Against private label, it costs more because there is work involved, but it produces a product the brand can distinguish rather than a base that a competitor may also be selling.

The comparison that matters is not the development cost but the cost of being wrong. A cheap development that produces a product the brand cannot support with a claim, or a texture the target customer rejects, is more expensive than a longer project that lands correctly. The hybrid route reduces the risk of a technical failure, because the base is proven, and it does not reduce the risk of a positioning failure, which is the brand's own call.

A realistic expectation for a fragrance, colour and packaging variation on a stocked base, with a stock pack, is ten to fourteen weeks from brief to dispatch, against sixteen to twenty-four for a full development. Both figures assume the artwork is approved in parallel rather than after the sample is signed off, which is where most timeline slippage actually sits.

Where a hybrid stops being the right answer

The first signal is the number of variables. A brand that wants a new fragrance, a different emulsifier, a raised active level, a new preservative and a novel texture is not customising a base; it is developing a product and should be quoted as one. The second is a claim that depends on a structure the base cannot deliver, such as a specific delivery system, a suspended phase or a texture the existing system cannot reach.

The third is a category the base does not sit in at all. A cleansing base cannot become a leave-on product, and an emulsion cannot become an anhydrous balm. Attempting the conversion costs more than starting fresh and produces a worse outcome, because the base's process and its documentation are both working against the change.

The fourth is scale. A brand with a firm forecast many times the manufacturer's normal batch size may find that a dedicated formula costs little more once the raw materials are bought in volume, and that owning the formula removes a dependency on a base that other brands can also buy. The threshold varies, but it is worth testing rather than assuming that hybrid stays cheaper forever.

Which changes trigger which studies

What to put in the brief

• The base the brand is starting from, and how it was validated.
• The exact list of variables the brand wants to change, in priority order.
• Which of those changes fall inside the base's proven envelope.
• The fragrance route: library selection or a development, and the dose range.
• The claim the product has to support, and whether the base can carry it.
• The packaging, and whether it uses stock tooling or a new drawing.
• The volume forecast, per variant and in total across the range.
• The development fee, and the terms on which it is credited against production.

Where our capability fits

We hold validated bases across skincare, hair care, body care and colour, and we can tell a brand early which of the changes it wants sit inside the proven envelope and which ones will restart a study. Where a project is genuinely a development rather than a variation, we say so at the brief stage rather than after the sampling loop.

We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development — whichever matches where your brand is today. Our lines include a firming face cream, a copper peptide repair serum and a hydrating soothing face cream, all of which are produced as bases that support defined variation.

Tell us the base you are considering and the changes you want, and we will come back with which ones are covered, which ones need a study and what each adds to the timeline. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. The model question itself is set out in our comparison of ODM, OEM and private label, and the base-versus-custom decision in our article on choosing between the two.

General manufacturing information, not regulatory or legal advice. Study requirements, safety assessment scope and notification obligations vary by market and by formula, and the applicable requirements should be confirmed for each product and destination before a formula is finalised.